Novo Integrated Sciences, Inc. (NVOS)

Market Cap	7.10M
Revenue (ttm)	22.58M
Net Income (ttm)	-12.36M
Shares Out	59.64M
EPS (ttm)	-0.45
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,467,353
Open	0.121
Previous Close	0.125
Day's Range	0.117 - 0.122
52-Week Range	0.101 - 3.320
Beta	-0.15
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 31, 2023

About NVOS

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services, and Product Manufacturing and Development. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and base...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Sep 22, 2017
• Employees: 73
• Stock Exchange: NASDAQ
• Ticker Symbol: NVOS

Financial Performance

In 2021, NVOS's revenue was $9.31 million, an increase of 18.38% compared to the previous year's $7.86 million. Losses were -$4.46 million, -9.22% less than in 2020.